Target intelligence / Profile preview

Solute carrier family 30 member 1 (ZnT1) (ZnT1)

Target
ZnT1
Molecular classification
Transporter, Cation transport protein, Solute carrier family
01

Overview

Zinc transporter 1 (ZnT1), encoded by the SLC30A1 gene, is a ubiquitous transmembrane protein and the primary exporter of zinc from the cytoplasm to the extracellular space [1.1.1, 1.3.4]. It is essential for maintaining cellular zinc homeostasis and protecting cells from zinc toxicity [1.1.5, 1.3.4]. Beyond its role in zinc transport, ZnT1 has been found to transport copper and interact with other signaling molecules, such as NMDA receptors and L-type calcium channels, thereby influencing neuronal excitability and calcium signaling [1.3.1, 1.3.2]. In disease contexts, ZnT1 is frequently dysregulated; its overexpression is associated with poor prognosis in several cancers, while its loss of function can lead to impaired metal homeostasis and increased susceptibility to oxidative stress [1.1.1, 1.3.1]. Therapeutic interest in ZnT1 is growing, with research exploring small-molecule modulators, RNA interference, and antibody-based approaches to treat conditions like cancer, Wilson disease, and neurodegenerative disorders [1.2.1, 1.3.1]. However, targeting ZnT1 presents challenges due to its critical role in systemic zinc balance and potential for off-target effects in the gut and brain [1.2.2, 1.3.1].

Other names
SLC30A1Zinc transporter 1ZNT1ZnT-1
02

Mechanism of action

Modulation of zinc efflux to regulate intracellular metal concentrations and downstream signaling pathways [1.2.1, 1.2.4].

03

Biological functions

Zinc effluxCopper transportMetal ion homeostasisRedox balanceImmune signalingProgrammed cell deathRegulation of neuronal excitability
04

Disease associations

CancerWilson diseaseAmyotrophic lateral sclerosisInflammatory disordersDiabetesCardiovascular disease
05

Safety considerations

Systemic zinc deficiencyImpaired intestinal barrier integrityNeurotoxicitySystemic toxicity
06

Interacting drugs

Zinc ionophores

2 more in the full profile.

07

Biomarkers

MT-2 mRNASerum zinc levelsZnT1 mRNA expression

Beyond the preview

Go deeper on Solute carrier family 30 member 1 (ZnT1) (ZnT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 30 member 1 (ZnT1) (ZnT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call